Mycronic AB (publ)
MICLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $19,540,744 | $12,440,085 | $12,847,886 | $11,164,538 |
| - Cash | $3,014,000 | $2,140,000 | $1,274,000 | $683,000 |
| + Debt | $219,000 | $228,000 | $270,000 | $243,000 |
| Enterprise Value | $16,745,744 | $10,528,085 | $11,843,886 | $10,724,538 |
| Revenue | $7,057,000 | $5,706,000 | $5,119,000 | $4,635,000 |
| % Growth | 23.7% | 11.5% | 10.4% | – |
| Gross Profit | $3,719,000 | $2,856,000 | $2,288,000 | $2,284,000 |
| % Margin | 52.7% | 50.1% | 44.7% | 49.3% |
| EBITDA | $2,365,000 | $1,388,000 | $1,112,000 | $1,152,000 |
| % Margin | 33.5% | 24.3% | 21.7% | 24.9% |
| Net Income | $1,683,000 | $998,000 | $741,000 | $828,000 |
| % Margin | 23.8% | 17.5% | 14.5% | 17.9% |
| EPS Diluted | 8.62 | 5.11 | 3.8 | 4.24 |
| % Growth | 68.7% | 34.5% | -10.4% | – |
| Operating Cash Flow | $1,874,000 | $1,608,000 | $853,000 | $998,000 |
| Capital Expenditures | -$126,000 | -$194,000 | -$141,000 | -$90,000 |
| Free Cash Flow | $1,748,000 | $1,414,000 | $712,000 | $908,000 |